T. Rowe Price Health Care ETF (TMED)
| Assets | $32.78M |
| Expense Ratio | 0.44% |
| PE Ratio | 32.76 |
| Forward PE | 23.49 |
| Shares Out | 975,000 |
| Dividend | $0.16 (0.48%) |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 14.78% |
| Volume | 20,558 |
| Open | 33.20 |
| Previous Close | 33.19 |
| Day's Range | 33.20 - 34.02 |
| 52-Week Low | 27.60 |
| 52-Week High | 36.72 |
| Beta | n/a |
| Holdings | 118 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The fund's investment portfolio concentrates primarily on health care equity. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
39.30% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 5.75% |
| UnitedHealth Group Incorporated | UNH | 5.32% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 5.28% |
| Thermo Fisher Scientific Inc. | TMO | 3.71% |
| Insulet Corporation | PODD | 3.64% |
| Cencora, Inc. | COR | 3.52% |
| Gilead Sciences, Inc. | GILD | 3.21% |
| Agilent Technologies, Inc. | A | 3.08% |
| Intuitive Surgical, Inc. | ISRG | 2.98% |
| Elanco Animal Health Incorporated | ELAN | 2.79% |
Performance
TMED had a total return of 22.62% in the past year, including dividends. Since the fund's inception, the average annual return has been 25.94%.
News
The Hidden Strength of Active Sector ETFs Spiking Right Now
Sector ETFs have long been a part of the overall ETF ecosystem. The ETF's transparency, flexibility, and tax efficiency have made it a vehicle for all sorts of sector strategies.
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...